May 22, 2017 / 4:02 PM / in 7 months

BUZZ-EyeGate Pharma: Achieves first milestone under Valeant deal

** Eye drug developer’s shares up 11.5 pct at $2.03

** EyeGate says it received its first development milestone payment from Valeant Pharmaceuticals International Inc under their 2015 deal

** Under deal, EyeGate has granted Valeant exclusive commercial and manufacturing rights to its delivery technology, and EGP-437, which is developed to treat post-operative ocular inflammation and pain

* EyeGate in Feb expanded the Valeant partnership

** Up to Friday’s close, EYEG had risen 11.7 pct this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below